Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

Autor: Gerard Platenburg, Jingjing Zang, Erwin van Wijk, Margo Dona, Sanne Broekman, Jiayi Miao, Cathaline den Besten, Erik de Vrieze, Hee Lam Chan, Janne J. Turunen, Hanka Venselaar, Lars Vorthoren, Kalyan Dulla, Peter Adamson, Ralph Slijkerman, Stephan C.F. Neuhauss, Silvia Albert, Wouter Beumer, Theo A. Peters, Iris Schmidt, Hester van Diepen, Ronald J.E. Pennings, Hannie Kremer, Levi Buil, Iris Schulkens
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Models
Molecular

Usher syndrome
Mutant
Induced Pluripotent Stem Cells
Biology
medicine.disease_cause
Retina
Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]
03 medical and health sciences
Exon
Mice
0302 clinical medicine
All institutes and research themes of the Radboud University Medical Center
Drug Discovery
Retinitis pigmentosa
otorhinolaryngologic diseases
Genetics
medicine
Animals
Humans
Outer nuclear layer
Molecular Biology
Zebrafish
Cells
Cultured

030304 developmental biology
Pharmacology
0303 health sciences
Mutation
Extracellular Matrix Proteins
Dose-Response Relationship
Drug

Vascular damage Radboud Institute for Molecular Life Sciences [Radboudumc 16]
Exons
Oligonucleotides
Antisense

Zebrafish Proteins
medicine.disease
biology.organism_classification
Molecular biology
Exon skipping
Disease Models
Animal

medicine.anatomical_structure
030220 oncology & carcinogenesis
Commentary
Molecular Medicine
Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]
Retinitis Pigmentosa
Zdroj: Molecular Therapy, 29, 8, pp. 2441-2455
Mol Ther
Molecular Therapy, 29, 2441-2455
ISSN: 1525-0016
Popis: Mutations in USH2A are among the most common causes of syndromic and non-syndromic retinitis pigmentosa (RP). The two most recurrent mutations in USH2A, c.2299delG and c.2276G > T, both reside in exon 13. Skipping exon 13 from the USH2A transcript presents a potential treatment modality in which the resulting transcript is predicted to encode a slightly shortened usherin protein. Morpholino-induced skipping of ush2a exon 13 in zebrafish ush2(armc1) mutants resulted in the production of usherin Delta exon 13 protein and a completely restored retinal function. Antisense oligonucleotides were investigated for their potential to selectively induce human USH2A exon 13 skipping. Lead candidate QR-421a induced a concentration-dependent exon 13 skipping in induced pluripotent stem cell (iPSC)-derived photoreceptor precursors from an Usher syndrome patient homozygous for the c.2299delG mutation. Mouse surrogate mQR-421a reached the retinal outer nuclear layer after a single intravitreal injection and induced a detectable level of exon skipping until at least 6 months post-injection. In conclusion, QR-421a-induced exon skipping proves to be a highly promising treatment option for RP caused by mutations in USH2A exon 13.
Databáze: OpenAIRE